30 completed, 14 recruiting, 13 terminated, 6 active not recruiting. 77 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 77 | Completed 30, Recruiting 14, Terminated 13, Active not recruiting 6, Not yet recruiting 6, Withdrawn 4, Unknown 3, Enrolling by invitation 1 |
Follow Brain Neoplasms: new trials by email Literature Review of Brain Neoplasms trials Research Report on Brain Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Asciminib With or Without Sildenafil for Brain Tumors Asciminib, Sildenafil, Surgical resection or biopsy - Brain Tumor | Early Phase 1 | Not yet recruiting | Washington University School of Medicine | 12 | 2026-10-31 | 2026-09-11 |
| Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures Panitumumab-IRDye800 - Meningioma, Glioblastoma | Early Phase 1 | Recruiting | Eben Rosenthal | 30 | 2026-07-07 | 2026-10-16 |
| AI in Endoscopic Transsphenoidal Surgery Live intra-op AI analysis of endoscopic video feed, with output displayed on supplementary monitor - Pituitary Adenoma | Early Phase 1 | Not yet recruiting | University College, London | 30 | 2026-06-01 | 2026-05-05 |
| QH101 Cell Injection in Patients With Brain, Brain (Spinal) Meninges, and Spinal Cord Metastatic Malignant Solid Tumors QH101 Cell Injection - Brain Metastasis, Meningeal Metastasis | Early Phase 1 | Not yet recruiting | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 7 | 2026-05-31 | 2026-06-18 |
| FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease Fluoro-O-(2) fluoroethyl-L-tyrosine (FET) PET - Cushing Disease, Pituitary Adenoma | Early Phase 1 | Recruiting | Mayo Clinic | 50 | 2026-04-27 | 2026-10-30 |
| Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG) Nivolumab, Nivolumab-IRDye800 - Brain Cancer, HGG | Early Phase 1 | Recruiting | Eben Rosenthal | 38 | 2026-03-27 | 2026-07-01 |
| A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies. SGT-53, hypofractionated radiotherapy with immunotherapy, Nivolumab - CNS Malignancies, Medulloblastoma Recurrent | Early Phase 1 | Recruiting | Children's National Research Institute | 18 | 2025-12-16 | 2026-04-29 |
| Contrast Enhanced Ultrasound in Neurosurgery to Improve Glioma Visualization and Border Demarcation Definity contrast during ultrasound - Glioma (Any Grade) in the Brain, Glioma | Early Phase 1 | Terminated | University of Colorado, Denver | 2 | 2025-12-05 | 2026-06-22 |
| Clinical Evaluation of [68Ga]Ga-NOTA-RF PET Imaging Targeting RFVT3 in Patients With Pituitary Tumors [68Ga]Ga-NOTA-RF - Pituitary Neoplasms | Early Phase 1 | Enrolling by invitation | Peking Union Medical College Hospital | 30 | 2025-11-17 | 2025-11-28 |
| Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation Cytarabine IT, hydrocortisone, Cisplatin - CNS Embryonal Tumor, CNS, Medulloblastoma | Early Phase 1 | Recruiting | C17 Council | 15 | 2025-09-23 | 2026-11-02 |
| Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion Lorlatinib, Lorlatinib with chemotherapy1, Lorlatinib with chemotherapy 2 - High Grade Glioma, Diffuse Intrinsic Pontine Glioma | Early Phase 1 | Recruiting | Nationwide Children's Hospital | 15 | 2025-08-03 | 2026-06-29 |
| Window of Opportunity Study of DSP-0390 in Gliomas DSP-0390 - Glioma, Malignant, IDH Mutation | Early Phase 1 | Recruiting | Washington University School of Medicine | 20 | 2025-04-03 | 2026-05-06 |
| Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery Remifentanil, Methadone - Brain Injury, Brain Tumors | Early Phase 1 | Recruiting | University of Virginia | 40 | 2025-03-10 | 2026-05-04 |
| Lipid Mediators & Cancer: Montelukast, SPM, and Almonds No Interventions, Sports Pro Resolve 4 g, Double Wood SPM 4 g - Colorectal Cancer, Sarcoma | Early Phase 1 | Not yet recruiting | University of South Florida | 56 | 2025-03-01 | 2025-03-20 |
| A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma Troriluzole - Glioblastoma, Recurrent Glioblastoma | Early Phase 1 | Recruiting | Ugonma Chukwueke | 27 | 2025-02-19 | 2025-09-11 |
| Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis 18F-Fluciclovine (Axumin) PET/CT - Brain Metastases | Early Phase 1 | Recruiting | University of Arizona | 20 | 2024-09-10 | 2026-09-21 |
| Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases Arginine, Biospecimen Collection, Computed Tomography - Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Solid Neoplasm | Early Phase 1 | Recruiting | Emory University | 10 | 2024-09-05 | 2026-10-13 |
| Azoles Targeting Recurrent High Grade Gliomas Ketoconazole (KCZ), Posaconazole (PCZ) - Brain Tumor, Recurrent, Cancer, Advanced | Early Phase 1 | Not yet recruiting | University Health Network, Toronto | 30 | 2024-06-01 | 2024-03-08 |
| Clinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma Vγ9Vδ2 T cell - GBM, DIPG Brain Tumor | Early Phase 1 | Not yet recruiting | Beijing Tiantan Hospital | 25 | 2024-04-30 | 2024-05-02 |
| A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors 68Ga-PSMA-11 PET Scans - High-grade Glioma, Brain Metastases | Early Phase 1 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 11 | 2024-01-05 | 2025-12-03 |
Showing 20 of 77. Sign in to see all of them.
Glioma (21) · Glioblastoma (17) · Diffuse Intrinsic Pontine Glioma (7) · Medulloblastoma (7) · Neoplasm Metastasis (6) · Neoplasms (5) · Pituitary Neoplasms (5) · Astrocytoma (4) · Breast Neoplasms (4) · Ependymoma (4) · Central Nervous System Neoplasms (3) · Lung Neoplasms (3) · Melanoma (3) · Ovarian Neoplasms (3)
Brain Diseases (77) · Central Nervous System Diseases (77) · Neoplasms by Site (77) · Nervous System Diseases (77) · Nervous System Neoplasms (77) · Central Nervous System Neoplasms (74) · Neoplasms (72) · Neoplasms by Histologic Type (49) · Neoplasms, Glandular and Epithelial (46) · Neoplasms, Nerve Tissue (45) · Neuroectodermal Tumors (45) · Neoplasms, Germ Cell and Embryonal (44) · Neoplasms, Neuroepithelial (43) · Glioma (20)
Magnetic Resonance Spectroscopy (6) · Temozolomide (5) · Bevacizumab (4) · Biopsy (3) · Nivolumab (3) · Carboplatin (2) · Cyclophosphamide (2) · Etoposide (2) · Filgrastim (2) · Fluorodeoxyglucose F18 (2) · Gemcitabine (2) · Granulocyte Colony-Stimulating Factor (2) · Irinotecan (2) · Ketoconazole (2) · Methotrexate (2)
Case Comprehensive Cancer Center (5) · M.D. Anderson Cancer Center (3) · Mayo Clinic (3) · The University of Texas Health Science Center, Houston (3) · Cedars-Sinai Medical Center (2) · Eben Rosenthal (2) · Emory University (2) · H. Lee Moffitt Cancer Center and Research Institute (2) · Memorial Sloan Kettering Cancer Center (2) · Milton S. Hershey Medical Center (2) · Nationwide Children's Hospital (2) · Northwestern University (2) · Peking Union Medical College Hospital (2) · St. Joseph's Hospital and Medical Center, Phoenix (2) · University of Colorado, Denver (2)
United States (62) · China (7) · Canada (4) · Germany (3) · Australia (2) · New Zealand (2) · Switzerland (2) · Brazil (1) · France (1) · Japan (1) · Mexico (1) · Netherlands (1) · United Kingdom (1)
Maryam Fouladi, MD (3) · David Sandberg, MD (2) · Nader Sanai, MD (2) · Susan Chi, MD (2) · Adam Green, MD (1) · Alireza Mansouri (1) · Alireza Mansouri, MD (1) · Annie Huang (1) · Anton Nosov, MD (1) · Ashok Srinivasan, M.D. (1) · Bital Savir-Baruch, MD (1) · Boris C Pasche, MD, PhD (1) · Carl Koschmann, M.D. (1) · Caroline Chung (1) · Chad Quarles (1)
PMID 19366446, PMID 25479121, PMID 31062234, PMID 32431667, PMID 34081125, PMID 34171339, PMID 35861778, PMID 38883740, PMID 39402027, PMID 39422741, PMID 41206763, PMID 41213248, PMID 42494994, PMID 42556340
P30CA138292 (2), P30CA012197 (1), P30CA013330 (1), P30CA014089 (1), P30CA043703 (1), P30CA068485 (1), P50CA108961 (1), R01CA178200 (1), R03CA255992 (1)